U.S. FDA Approves Merck's ENFLONSIA\u2122 (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respirato

• click to rate

  Posted by Two Blokes Jun 9 - Filed in Stock - 2 views
  
  RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--U.S. FDA Approves Merck's ENFLONSIA for Prevention of RSV Lower Respiratory Tract Disease in Infants Born During or Entering Their First RSV Season.